跳至主要内容
临床试验/NCT05743361
NCT05743361已完成不适用

Studio Sierologico in Volontari Vaccinati Contro COVID-19

Istituto Auxologico Italiano1 个研究点 分布在 1 个国家目标入组 540 人开始时间: 2021年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
540
试验地点
1
主要终点
Change in Autoantibody Levels

研究概览

简要总结

Preliminary data support a possible molecular mimicry between SARS-CoV-2 and autologous components. This suggests the occurrence of autoimmunity during COVID-19. Consistently, autoimmunity may occur after SARS-CoV2 vaccination. The study aims to investigate the production of autoantibodies after vaccination in healtcare workers.

详细描述

Healtcare workers undergoing SARS-CoV-2 vaccination (with RNA-vaccines) will be included on a voluntary basis. Blood samples will be collected before and after vaccination (1 -3 - 6 - 12 months). All the vaccination side effects will be registered.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthcare workers undergoing SARS-CoV-2 vaccination

排除标准

  • Pregnancy
  • Full blown autoimmune diseases
  • Active vaccinations within 3 months before enrolment (excluding the influenza vaccine)
  • Previous vaccination severe side effects

结局指标

主要结局

Change in Autoantibody Levels

时间窗: Before vaccination and 1, 6 and 12 months after vaccination

ANA, AMA, anti-dsDNA, anti-ENA, anti-MPO, anti-PR3, aPL, RF, ACPA, anti-TPO, anti-TG

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验